PDPHF
Egetis Therapeutics AB

0
52W High
$0.6353
Volume
7,870.00
52W Low
$0.6353
Price
$0.6353
Open
$0.6353
PDPHF Fundamentals
50D MA
$0.6353
Beta
0.00
Avg. Volume
0.00
Loading...
Loading...

About

Egetis Therapeutics AB is an innovative and integrated pharmaceutical company, which engages in the development of new drugs for treatment of serious diseases. Its projects include Emcitate for the treatment of patients with monocarboxylate transporter 8 (MCT8) deficiency. The company was founded by Torsten Almén, Heidi Brurok, Louis J. Ignarro, Per Jynge, Jan Olof Gustav Karlsson, Ingemar Lundström, and Rob Towart in 2006 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for Egetis Therapeutics AB?
What is the 52-week low for Egetis Therapeutics AB?
What is Egetis Therapeutics AB stock price today?
What is the 50-day moving average of Egetis Therapeutics AB?

Latest PDPHF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.